Darunavir
Who holds supplier records for Darunavir? 9 organisations hold a current record for Darunavir: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (8) and Belgium (1).
Most records are filed under another form of this substance: Darunavir Ethanolate (10 current sources). A DMF or CEP is listed under the form it names.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Darunavir: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/darunavir
Reading the evidence
- 9 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
8 of the 9 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Darunavir expires 26 Jun 2027. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (9)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Darunavir. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Cipla LimitedIndia Company GMP cert on recordActive DMF 23660, 23661, 40826 +1 · latest filing Jan 2025
- Hetero Labs LimitedIndia Company GMP cert on recordActive DMF 35834, 23854 · latest filing Apr 2021
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 23873, 30596 · latest filing Jun 2016
- INNOVARE LABS PRIVATE LTDIndiaActive DMF 35508 · latest filing Feb 2021
- Janssen Pharmaceutica NVBelgium Company GMP cert on recordActive DMF 18825 · latest filing Nov 2005
- Laurus Labs LimitedIndia Company GMP cert on recordActive DMF 31198 · latest filing Oct 2017
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 30882 · latest filing Oct 2016
- RAKS PHARMA PVT LTDIndiaActive DMF 30803 · latest filing Oct 2016
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 33895 · latest filing May 2019
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Darunavir are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- Zhejiang Jiuzhou Pharmaceutical Co., Ltd.China · Inactive DMF 27436, 31494 · filed Feb 2017
- India · Inactive DMF 29455 · filed Aug 2015
- India · Inactive DMF 27038 · filed Apr 2013
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (28 listed products contain Darunavir). The latest listed patent expires 26 Jun 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Darunavir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1323).
Chemical identity
- IUPAC name
- [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate
- Canonical SMILES
- CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
- InChIKey
- CJBJHOAVZSMMDJ-HEXNFIEUSA-N
- Synonyms
- (-)-darunavir, Darunavir, Darunavir component of prezcobix, Darunavir component of symtuza, Darunavir krka, Darunavir krka d.d., Darunavir viatris (previously darunavir mylan), Prezista, TMC 114, TMC-114, TMC114, TMC-41629
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Protease Inhibitor
- Mechanism of action
- Cytochrome P450 2D6 Inhibitors; Cytochrome P450 3A Inhibitors; HIV Protease Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Darunavir?
9 organisations hold an active US FDA Type II Drug Master File or a CEP for Darunavir: Cipla Limited (India), Hetero Labs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), INNOVARE LABS PRIVATE LTD (India), Janssen Pharmaceutica NV (Belgium), Laurus Labs Limited (India), MSN LIFE SCIENCES PRIVATE LIMITED (India) and RAKS PHARMA PVT LTD (India), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Darunavir Drug Master Files are active?
Cipla Limited (DMF 23660, 23661), Hetero Labs Limited (DMF 35834, 23854), MATRIX PHARMACORP PRIVATE LTD (DMF 23873, 30596), INNOVARE LABS PRIVATE LTD (DMF 35508), Janssen Pharmaceutica NV (DMF 18825), Laurus Labs Limited (DMF 31198), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 30882) and RAKS PHARMA PVT LTD (DMF 30803) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Darunavir records mean?
3 organisations have only inactive Type II DMFs for Darunavir. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Darunavir?
Yes. The latest patent listed for an approved US product containing Darunavir expires 26 Jun 2027, across 28 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Darunavir supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Darunavir?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.